A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era.
<h4>Background</h4>Studies in populations unexposed to folic acid (FA) fortification have demonstrated that MTHFR C677T polymorphism is associated with increased risk of higher grades of cervical intraepithelial neoplasia (CIN 2+). However, it is unknown whether exposure to higher folate...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1e41ead091374b529529b272f37af096 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1e41ead091374b529529b272f37af096 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1e41ead091374b529529b272f37af0962021-11-25T05:57:12ZA lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era.1932-620310.1371/journal.pone.0110093https://doaj.org/article/1e41ead091374b529529b272f37af0962014-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0110093https://doaj.org/toc/1932-6203<h4>Background</h4>Studies in populations unexposed to folic acid (FA) fortification have demonstrated that MTHFR C677T polymorphism is associated with increased risk of higher grades of cervical intraepithelial neoplasia (CIN 2+). However, it is unknown whether exposure to higher folate as a result of the FA fortification program has altered the association between MTHFR C677T and risk of CIN, or the mechanisms involved with such alterations. The current study investigated the following in a FA fortified population: 1) The association between MTHFR C677T polymorphism and risk of CIN 2+; 2) The modifying effects of plasma folate concentrations on this association; and 3) The modifying effects of plasma folate on the association between the polymorphism and degree of methylation of long interspersed nucleotide elements (L1s), in peripheral blood mononuclear cell (PBMC) DNA, a documented biomarker of CIN risk.<h4>Methods</h4>The study included 457 US women diagnosed with either CIN 2+ (cases) or ≤ CIN 1 (non-cases). Unconditional logistic regression models were used to test the associations after adjusting for relevant risk factors for CIN.<h4>Results</h4>The 677CT/TT MTHFR genotypes were not associated with the risk of CIN 2+. Women with CT/TT genotype with lower folate, however, were more likely to be diagnosed with CIN 2+ compared to women with CT/TT genotype with higher folate (OR = 2.41, P = 0.030). Women with CT/TT genotype with lower folate were less likely to have a higher degree of PBMC L1 methylation compared to women with CT/TT genotype with higher folate (OR = 0.28, P = 0.017).<h4>Conclusions</h4>This study provides the first evidence that the MTHFR 677CT/TT genotype-associated lower degree of PBMC L1 methylation increases the risk of CIN 2+ in women in the US post-FA fortification era. Thus, even in the post-FA fortification era, not all women have adequate folate status to overcome MTHFR 677CT/TT genotype-associated lower degree of L1 methylation.Suguna BadigaGary L JohanningMaurizio MacalusoAndres AzueroMichelle M ChambersNuzhat R SiddiquiChandrika J PiyathilakePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 10, p e110093 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Suguna Badiga Gary L Johanning Maurizio Macaluso Andres Azuero Michelle M Chambers Nuzhat R Siddiqui Chandrika J Piyathilake A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era. |
description |
<h4>Background</h4>Studies in populations unexposed to folic acid (FA) fortification have demonstrated that MTHFR C677T polymorphism is associated with increased risk of higher grades of cervical intraepithelial neoplasia (CIN 2+). However, it is unknown whether exposure to higher folate as a result of the FA fortification program has altered the association between MTHFR C677T and risk of CIN, or the mechanisms involved with such alterations. The current study investigated the following in a FA fortified population: 1) The association between MTHFR C677T polymorphism and risk of CIN 2+; 2) The modifying effects of plasma folate concentrations on this association; and 3) The modifying effects of plasma folate on the association between the polymorphism and degree of methylation of long interspersed nucleotide elements (L1s), in peripheral blood mononuclear cell (PBMC) DNA, a documented biomarker of CIN risk.<h4>Methods</h4>The study included 457 US women diagnosed with either CIN 2+ (cases) or ≤ CIN 1 (non-cases). Unconditional logistic regression models were used to test the associations after adjusting for relevant risk factors for CIN.<h4>Results</h4>The 677CT/TT MTHFR genotypes were not associated with the risk of CIN 2+. Women with CT/TT genotype with lower folate, however, were more likely to be diagnosed with CIN 2+ compared to women with CT/TT genotype with higher folate (OR = 2.41, P = 0.030). Women with CT/TT genotype with lower folate were less likely to have a higher degree of PBMC L1 methylation compared to women with CT/TT genotype with higher folate (OR = 0.28, P = 0.017).<h4>Conclusions</h4>This study provides the first evidence that the MTHFR 677CT/TT genotype-associated lower degree of PBMC L1 methylation increases the risk of CIN 2+ in women in the US post-FA fortification era. Thus, even in the post-FA fortification era, not all women have adequate folate status to overcome MTHFR 677CT/TT genotype-associated lower degree of L1 methylation. |
format |
article |
author |
Suguna Badiga Gary L Johanning Maurizio Macaluso Andres Azuero Michelle M Chambers Nuzhat R Siddiqui Chandrika J Piyathilake |
author_facet |
Suguna Badiga Gary L Johanning Maurizio Macaluso Andres Azuero Michelle M Chambers Nuzhat R Siddiqui Chandrika J Piyathilake |
author_sort |
Suguna Badiga |
title |
A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era. |
title_short |
A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era. |
title_full |
A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era. |
title_fullStr |
A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era. |
title_full_unstemmed |
A lower degree of PBMC L1 methylation in women with lower folate status may explain the MTHFR C677T polymorphism associated higher risk of CIN in the US post folic acid fortification era. |
title_sort |
lower degree of pbmc l1 methylation in women with lower folate status may explain the mthfr c677t polymorphism associated higher risk of cin in the us post folic acid fortification era. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/1e41ead091374b529529b272f37af096 |
work_keys_str_mv |
AT sugunabadiga alowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT garyljohanning alowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT mauriziomacaluso alowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT andresazuero alowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT michellemchambers alowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT nuzhatrsiddiqui alowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT chandrikajpiyathilake alowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT sugunabadiga lowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT garyljohanning lowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT mauriziomacaluso lowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT andresazuero lowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT michellemchambers lowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT nuzhatrsiddiqui lowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera AT chandrikajpiyathilake lowerdegreeofpbmcl1methylationinwomenwithlowerfolatestatusmayexplainthemthfrc677tpolymorphismassociatedhigherriskofcinintheuspostfolicacidfortificationera |
_version_ |
1718414326190047232 |